Mr. Speaker, in mid-April, researchers at the St. Boniface Hospital Research centre announced an important scientific breakthrough that could help in the fight against antibiotic-resistant bacteria. PEG-2S, which could help in the fight against antibiotic-resistant bacteria, was developed by Dr. Grant Pierce and Dr. Pavel Dibrov to combat two of the top 10 antibiotic-resistant priority pathogens. This antibiotic is novel in that it does not affect healthy cells. It only targets bacterial cells that act as a form of energy supply that help the harmful bacteria proliferate.
Although we have to wait until this new drug passes through the necessary steps in order to reach pharmacy shelves, this announcement is important for the international medical community and represents the first potential discovery of a new antibiotic in the past 30 years.
This is a reminder of the impressive work being done every day by researchers at the St. Boniface Hospital Research Centre.